ONA Therapeutics
Lucia Suarez-Lopez is a Senior Scientist at ONA Therapeutics, focusing on exploring metabolic vulnerabilities of metastatic stem cells for advanced cancer patients. With a background in systems biology and inflammatory diseases, Lucia has held positions at Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Massachusetts Institute of Technology, and VHIR Vall d’Hebron Institut de Recerca. Lucia's research has centered around intestinal inflammation, chronic inflammation, and colon tumorigenesis, with a particular focus on identifying therapeutic opportunities for conditions like Inflammatory Bowel Disease. With a strong academic background, including a PhD in Biomedicine, Lucia brings a wealth of knowledge and expertise to their scientific endeavors.
ONA Therapeutics
Ona Therapeutics is a biotech company, spin-off of ICREA and IRB, specialized in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism.